Unequal Behaviour between Hydrolysable Functions of Nirmatrelvir under Stress Conditions: Structural and Theoretical Approaches in Support of Preformulation Studies

• 主要な著者: Philippe-Henri Secretan (著者), Maxime Annereau (著者), Willy Kini-Matondo (著者), Bastien Prost (著者), Jade Prudhomme (著者), Lina Bournane (著者), Muriel Paul (著者), Najet Yagoubi (著者), Hassane Sadou-Yayé (著者), Bernard Do (著者)
• フォーマット: 図書
• 出版事項: MDPI AG, 2022-08-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Nirmatrelvir is an antiviral drug approved for the treatment of COVID-19. The available dosage form consists of tablets marketed under the brand name PAXLOVID^®. Although knowledge of nirmatrelvir's intrinsic stability may be useful for any potential development of other p...